nandrolone decanoate (Decadurabolin)

Subscribe to Selected New Research on nandrolone decanoate

154 relevant articles (8 outcomes, 32 trials/studies) found for this Drug

Description: structure; used in the treatment of HIV wasting disease

Also Known As:

Decadurabolin; 17 beta-hydroxyestr-4-en-3-one 17-decanoate; 19-nor-4-androstene-17 beta-ol-3-one 17-decanoate; 19-nortestosterone decanoate; Decadurobolin; Retabolil; Retabolyl

Relationship Network

Drug Context: Research Results

Polycyclic Compounds: 58

nandrolone decanoate: 154

Hormones, Hormone Substitutes, and Hormone Antagonists

Hormones: 44070

Gonadal Hormones: 245

Gonadal Steroid Hormones: 2145

Testosterone Congeners: 17

Nandrolone: 159

nandrolone decanoate: 154

Experts

1.	Busato, Vera Cristina W: 1 article (01/2008)
2.	Santos, Maria Carmen S: 1 article (01/2008)
3.	Moysés, Margareth R: 1 article (01/2008)
4.	Andrade, Tadeu U: 1 article (01/2008)
5.	Abreu, Gláucia R: 1 article (01/2008)
6.	Bissoli, Nazaré S: 1 article (01/2008)
7.	Medeiros, Ana Raquel S: 1 article (01/2008)
8.	Buranaosot, Somphon: 1 article (05/2007)
9.	Eiam-Ong, Somchit: 1 article (05/2007)
10.	Eiam-Ong, Somchai: 1 article (05/2007)

Related Diseases

1.	Anemia 01/01/2005 - "Our target is to assess the safety and the efficacy of nandrolone decanoate (ND) as an effective adjunctive therapy to treat such anemia" 11/01/1988 - "Nandrolone decanoate therapy for anemia in patients on haemodialysis." 04/01/1983 - "Symptomatic palliation of the severe anemia was attained in this patient by injections of nandrolone decanoate" 01/01/1999 - "OBJECTIVE: To assess the efficiency of nandrolone decanoate (ND) in the control of anemia in elderly male patients on hemodialysis (HD), and to determine its influence on nutritional parameters" 01/01/1999 - "Nandrolone decanoate is a good alternative for the treatment of anemia in elderly male patients on hemodialysis." Get all the results and reference details, order at left...
2.	HIV Infections (HIV Infection) 06/01/1996 - "Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection." 03/14/2005 - "CONCLUSION: Nandrolone decanoate therapy may prove to be generally safe and beneficial in reversing weight loss and lean tissue loss in women with HIV infection and other chronic catabolic diseases." 09/01/1996 - "A randomized study of nandrolone decanoate (Deca-Durabolin) showed that the anabolic steroid can increase weight in people with HIV infections" Get all the results and reference details, order at left...
3.	Weight Loss (Weight Reduction) 03/14/2005 - "Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial." 02/01/1999 - "Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss." 07/01/1986 - "There was a trend for less severe weight loss on the nandrolone decanoate arm (average weight loss 0.8 +/- 0.15 kg versus 0.21 +/- 0.18 kg, respectively), with half as many patients experiencing weight loss on nandrolone decanoate (25% versus 12%)" 03/14/2005 - "CONCLUSION: Nandrolone decanoate therapy may prove to be generally safe and beneficial in reversing weight loss and lean tissue loss in women with HIV infection and other chronic catabolic diseases." 07/01/1986 - "Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer." Get all the results and reference details, order at left...
4.	Chronic Obstructive Pulmonary Disease (COPD) 10/01/1995 - "Two hundred seventeen patients with COPD participated in a placebo-controlled, randomized trial investigating the physiologic effects of nutritional intervention alone (N) for 8 wk or combined with the anabolic steroid nandrolone decanoate (N + A)" 01/01/2008 - "Sixteen patients with severe COPD were randomized to either placebo or nandrolone decanoate" 01/01/2008 - "Administration of anabolic steroids (nandrolone decanoate) outside a dedicated rehabilitation program did not lead to either weight gain, improvement in physiological function, or better quality of life in patients with severe COPD." 11/01/2003 - "PATIENTS AND METHODS: We randomly assigned 63 male patients with COPD to receive on days 1, 15, 29, and 43 a deep IM injection of 50 mg of nandrolone decanoate (ND) [Deca-Durabolin; N.V. Organon; Oss, The Netherlands] in 1 mL of arachis oil, or 1 mL of arachis oil alone (placebo) in a double-blind design" Get all the results and reference details, order at left...
5.	Chronic Kidney Failure (Chronic Renal Failure) 10/01/1997 - "We conclude that the combination of low-dose rHuEPO and nandrolone decanoate is effective treatment for the anemia of end-stage renal failure." 04/01/2001 - "The role of nandrolone decanoate in patients with end stage renal disease in the erythropoietin era." 01/01/1978 - "A double blind cross-over trial of Nandrolone decanoate (Decadurabolin) was carried out in 27 patients with anaemia due to end stage renal disease, stabilised on regular haemodialysis" Get all the results and reference details, order at left...
77 Diseases and 154 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Steroids
2.	alvesin
3.	Methylprednisolone
4.	Calcium
5.	Testosterone (Sustanon)
6.	nandrolone decanoate (Decadurabolin)
7.	Tamoxifen
8.	nandrolone phenpropionate (Durabolin)
9.	Erythropoietin
10.	Calcitonin (Calcitonin, Eel)
111 Drugs and Important Bio-Agents and 92 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Renal Dialysis (Hemodialysis)
2.	Hormone Replacement Therapy (Therapy, Hormone Replacement)
3.	Combination Drug Therapy (Combination Chemotherapy)
4.	Highly Active Antiretroviral Therapy (HAART)
5.	Continuous Ambulatory Peritoneal Dialysis (CAPD)
6 Therapies and Procedures and 13 more articles analyzed in the Research Interface, order at left...

Research Interface Subscription

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Searches
2 clicks from Disease to Drug to Evidence
Trial references
All the Positive Outcomes
Drug and Therapy searches
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface Subscription

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>